Effect of selenium on lipid profile, Weight gain and Physical Activity in hemodialysis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190622043973N1

Enrollment

Registered

2019-08-09

Start date

2019-07-06

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End stage renal disease. Chronic kidney disease, stage 5

Interventions

Intervention 1: Intervention group: 2 selenium pills (200 micrograms) from Webber Naturals Canada after each hemodialysis (3 times a week) for 3 months. Intervention 2: Control group: 2 Placebo (Starc

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: At least 6 months passing after hemodialysis starting The patient's willingness to cooperate

Exclusion criteria

Exclusion criteria: Hepatitis Skeletal disorder Steroidal and non-steroidal anti-inflammatory drugs within two months before the study

Design outcomes

Primary

Measure	Time frame
Serum triglyceride levels. Timepoint: Before starting the study and 3 months after the intervention began. Method of measurement: Autoanalyser.;Total serum cholesterol level. Timepoint: Before starting the study and 3 months after the intervention began. Method of measurement: Autoanalyser.;Weighing. Timepoint: Before starting the study and 3 months after the intervention began. Method of measurement: Scale.;Physical activity. Timepoint: Before starting the study and 3 months after the intervention began. Method of measurement: Five times sit to stand test.	—

Measure

Time frame

Serum triglyceride levels. Timepoint: Before starting the study and 3 months after the intervention began. Method of measurement: Autoanalyser.;Total serum cholesterol level. Timepoint: Before starting the study and 3 months after the intervention began. Method of measurement: Autoanalyser.;Weighing. Timepoint: Before starting the study and 3 months after the intervention began. Method of measurement: Scale.;Physical activity. Timepoint: Before starting the study and 3 months after the intervention began. Method of measurement: Five times sit to stand test.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamed Mohamadian Shoeili

Esfahan University of Medical Sciences

hamed429@resident.mui.ac.ir+98 31 3668 8597

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026